DaBomb Protein Biotech Past Earnings Performance
Past criteria checks 0/6
DaBomb Protein Biotech's earnings have been declining at an average annual rate of -61.7%, while the Personal Products industry saw earnings growing at 13.2% annually. Revenues have been declining at an average rate of 11.1% per year.
Key information
-61.7%
Earnings growth rate
-58.7%
EPS growth rate
Personal Products Industry Growth | 13.9% |
Revenue growth rate | -11.1% |
Return on equity | -6.0% |
Net Margin | -14.8% |
Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How DaBomb Protein Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 384 | -57 | 63 | 14 |
30 Sep 23 | 399 | -66 | 66 | 13 |
30 Jun 23 | 399 | -43 | 64 | 12 |
31 Mar 23 | 418 | -47 | 65 | 12 |
31 Dec 22 | 434 | -45 | 70 | 12 |
30 Sep 22 | 445 | -45 | 73 | 11 |
30 Jun 22 | 465 | -52 | 74 | 12 |
31 Mar 22 | 457 | -46 | 72 | 11 |
31 Dec 21 | 471 | -62 | 74 | 12 |
30 Sep 21 | 531 | -49 | 77 | 13 |
30 Jun 21 | 580 | -26 | 80 | 14 |
31 Mar 21 | 626 | -14 | 77 | 14 |
31 Dec 20 | 605 | 7 | 70 | 14 |
30 Sep 20 | 544 | 3 | 62 | 14 |
30 Jun 20 | 570 | -1 | 65 | 13 |
31 Mar 20 | 603 | 6 | 74 | 13 |
31 Dec 19 | 647 | 21 | 79 | 11 |
30 Sep 19 | 676 | 32 | 86 | 10 |
30 Jun 19 | 652 | 33 | 85 | 8 |
31 Mar 19 | 622 | 29 | 82 | 7 |
31 Dec 18 | 623 | 25 | 80 | 6 |
30 Sep 18 | 619 | 26 | 80 | 5 |
30 Jun 18 | 610 | 32 | 78 | 5 |
31 Mar 18 | 600 | 29 | 78 | 5 |
31 Dec 17 | 562 | 28 | 75 | 5 |
30 Sep 17 | 593 | 35 | 75 | 5 |
30 Jun 17 | 626 | 40 | 76 | 5 |
31 Mar 17 | 661 | 54 | 75 | 5 |
31 Dec 16 | 727 | 68 | 79 | 5 |
30 Sep 16 | 726 | 70 | 76 | 6 |
30 Jun 16 | 725 | 71 | 74 | 7 |
31 Mar 16 | 765 | 67 | 72 | 7 |
31 Dec 15 | 805 | 62 | 71 | 7 |
31 Dec 14 | 802 | 28 | 65 | 4 |
31 Dec 13 | 736 | 13 | 53 | 4 |
Quality Earnings: 6578 is currently unprofitable.
Growing Profit Margin: 6578 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6578 is unprofitable, and losses have increased over the past 5 years at a rate of 61.7% per year.
Accelerating Growth: Unable to compare 6578's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6578 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (25.3%).
Return on Equity
High ROE: 6578 has a negative Return on Equity (-5.95%), as it is currently unprofitable.